ReferenceID 2106
Indole supplementation ameliorates MCD-induced NASH in mice
J Nutr Biochem
Indole is a microbiota metabolite that functions to protect against obesity-associated non-alcoholic fatty liver disease. The present study examined the extent to which indole supplementation alleviates the severity of n
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final reference record.
- Reference Id
- 2106
- Evidence Id
- 18696
- Core Evidence Id
- 18696
- Source Reference Id
- 4235
- Herb2 Reference Id
- HBREF005032
- Subject Paper Key
- HBIN030110_35568098
- Pubmed Id
- 35568098
- Doi
- 10.1016/j.jnutbio.2022.109041
- Paper Title
- Indole supplementation ameliorates MCD-induced NASH in mice
- Paper Abstract
- Indole is a microbiota metabolite that functions to protect against obesity-associated non-alcoholic fatty liver disease. The present study examined the extent to which indole supplementation alleviates the severity of non-alcoholic steatohepatitis (NASH), which is the advanced form of non-alcoholic fatty liver disease. In C57BL/6J mice, feeding a methionine- and choline-deficient diet (MCD) resulted in significant weight loss, overt hepatic steatosis, and massive aggregations of macrophages in the liver compared with control diet-fed mice. Upon indole supplementation, the severity of MCD-induced hepatic steatosis and inflammation, as well as liver fibrosis, was significantly decreased compared with that of MCD-fed and control-treated mice. In vitro, indole treatment caused significant decreases in lipopolysaccharide-induced proinflammatory responses in hepatocytes incubated with either basal or MCD-mimicking media. However, indole treatment only significantly decreased lipopolysaccharide-induced proinflammatory responses in bone marrow-derived macrophages incubated with basal, but not MCD-mimicking media. These differential effects suggest that, relative to the responses of macrophages to indole, the responses of hepatocytes to indole appeared to make a greater contribution to indole alleviation of NASH, in particular liver inflammation. While indole supplementation decreased liver expression of desmin in MCD-fed mice, treatment of LX2 cells (a line of hepatic stellate cells) with indole also decreased the expression of various markers of hepatic stellate cell fibrogenic activation. Lastly, indole supplementation decreased intestinal inflammation in MCD-fed mice, suggesting that decreased intestinal inflammation also was involved in indole alleviation of NASH. Collectively, these results demonstrate that indole supplementation alleviates MCD-induced NASH, which is attributable to, in large part, indole suppression of hepatocyte proinflammatory responses and hepatic stellate cell fibrogenic activation, as well as intestinal proinflammatory responses.
- Journal
- J Nutr Biochem
- Publish Year
- 2022
- Experiment Subject
- mouse; lx2 cells
- Experiment Type
- Animal & Cell Experiment
- Phenotype Related
- Obesity; Hepatic Steatosis; Non-alcoholic Steatohepatitis; Inflammation; Non-alcoholic Fatty Liver Disease; Liver Inflammation; Weight Loss; Diet-fed; Liver Fibrosis
- Paper Title Cn
- Paper Title En
- Indole supplementation ameliorates MCD-induced NASH in mice
- Bilingual Status
- semi_complete